A CRISPR Look at COVID-19

Simple item page
dc.contributor.authorChing, Jolie
dc.contributor.authorNakamura, Shane
dc.date.accessioned2021-10-28T02:50:56Z
dc.date.available2021-10-28T02:51:03Z
dc.date.issued2020-12-18
dc.description.abstractThe largest pandemic in recent times -- novel coronavirus disease 2019 (COVID-19) -- has caused economic shutdowns and social isolation on a global scale. Life as we know it has been placed on hold for the time being. Meanwhile, the scientific community worldwide is trying to understand COVID-19 biology and search for detection methods, prevention strategies, and treatments. Many researchers and biotech companies are turning to CRISPR, a cutting-edge advancement in biotechnology, to aid in developing methods for detection and finding a treatment for the virus. As a result, the need for unified regulation on CRISPR is more apparent than ever.
dc.identifier.urihttp://hdl.handle.net/10125/76712
dc.titleA CRISPR Look at COVID-19
dc.typeArticle
prism.number1
prism.volume5

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2021-Ching-J-and-Nakamura-S.pdf
Size:
103.78 KB
Format:
Adobe Portable Document Format
Download

Collections

Horizons, Volume 5